Last edition
News about "Ascent Capital"
Strides Pharma Science has sold a majority stake in its subsidiary, Pivot Path, to an Ascent Capital-led investor consortium for INR 100 crore, alongside a fresh INR 50 crore capital infusion that will support the company's expansion as an independent life sciences and digital transformation services provider.
Ascent Capital | 29/06/2026 | By News Bureau
Symbio Generrics completes capital raise from Ascent Capital
The funds raised from Ascent will be utilised towards undertaking strategic acquisitions, establishing a best-in-class R&D facility and ramping up manufacturing capacity
<br />
Ascent Capital | 25/11/2022 | By Sudeep Soparkar | 990
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy